Mouse Strain-related Variation as a Factor in the Pathogenesis of Coxsackievirus B3 Murine Myocarditis

References

1. Alter B. J., Bach F. M. 1982; Histocompatibility and isoenzyme differences in commercially supplied Balb/c mice. Science 217:379–381
   [Google Scholar]
2. Berger M. L., Blanden R. V. 1981; The T lymphocytes in infectious pathology. Pathology, Research and Practice 171:128–141
   [Google Scholar]
3. Gatmaiton B. G., Chason I. L., Lerner A. M. 1970; Augmentation of the virulence of murine coxsackie virus B3 myocarditis by exercise. Journal of Experimental Medicine 131:1121–1136
   [Google Scholar]
4. Gilden D. H., Cole G. A., Monjan A. A., Nathanson N. 1972; Immunopathogenesis of acute nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction of the virus-carrier state in adult mice. Journal of Experimental Medicine 135:860–873
   [Google Scholar]
5. Grun J. B., Schultz M., Crowell R. L., Landau B. J. 1984; Development of coxsackievirus B-3 induced myocarditis in the absence of specific cytotoxic T cell activity. In Abstracts of the Annual Meeting of the American Society for MicrobiologyT22 Washington, D.C: American Society for Microbiology;
   [Google Scholar]
6. Gudvangen R. J., Duffey P. S., Paque R. E., Gauntt C. J. 1983; Levamisol exacerbates coxsackievirus B-3 induced murine myocarditis. Infection and Immunity 41:1157–1165
   [Google Scholar]
7. Guthrie M., Lodge P. A., Huber S. A. 1984; Cardiac injury in myocarditis induced by coxsackievirus group B type 3 in Balb/c mice is mediated by lyt 2⁺ cytolytic lymphocytes. Cellular Immunology 88:558–567
   [Google Scholar]
8. Hashimoto I., Komatsu T. 1978; Myocardial changes after infection with coxsackie virus B3 in nude mice. British Journal of Experimental Pathology 59:13–20
   [Google Scholar]
9. Hashimoto I., Tatsumi M., Nakagawa M. 1983; The role of T lymphocytes in pathogenesis of coxsackievirus B3 heart disease. British Journal of Experimental Pathology 64:497–504
   [Google Scholar]
10. Herskowitz A., Beisel K. W., Wolfgram L. I., Rose N. R. 1985; Coxsackievirus B3 myocarditis: wide pathologic spectrum in genetically defined inbred strains. Human Pathology 16:671–673
    [Google Scholar]
11. Huber S. A., Job L. P. 1983; Cellular immune mechanisms in coxsackievirus group B type 3 induced myocarditis. Advances in Experimental Medicine and Biology 161:491–508
    [Google Scholar]
12. Huber S. A., Lodge P. A. 1984; Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. American Journal of Pathology 116:21–29
    [Google Scholar]
13. Huber S. A., Job L. p., Woodruff J. F. 1980; Lysis of infected myofibers by coxsackievirus B-3 murine T lymphocytes. American Journal of Pathology 98:681–694
    [Google Scholar]
14. Huber S. A., Job L. P. 1982; Influence of sex hormone on coxsackie B3 virus infection in Balb/c mice. Cellular Immunology 67:173–189
    [Google Scholar]
15. Huber S. A., Job L. P., Woodruff J. F. 1984; In vitro culture of coxsackie group B type 3 immune spleen cells on infected endothelial cells and biologic activity of the cultured cells in vivo. Infection and Immunity 43:567–573
    [Google Scholar]
16. Khatib R., Chason J. L., Silberberg B. K., Lerner A. M. 1980; Age-dependent pathogenicity of group B coxsackieviruses in Swiss Webster mice: infectivity for myocardium and pancreas. Journal of Infectious Diseases 141:394–403
    [Google Scholar]
17. Kilbourne E. D., Wilson C. B., Perrier D. 1956; The induction of gross myocardial lesions by a coxsackie (pleurodenia) virus and cortisone. Journal of Clinical Investigation 35:362–370
    [Google Scholar]
18. Lyden D. c., Huber S. A. 1984; Aggravation of coxsackievirus group B type 3 induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with progesterone. Cellular Immunology 87:462–472
    [Google Scholar]
19. Melnick J. L., Ledinko N. 1950; Immunologic reactions of coxsackie viruses; neutralization test: technique and application. Journal of Experimental Medicine 92:463–482
    [Google Scholar]
20. Melnick J. L., Wenner H. A., Phillips C. A. 1979; Enteroviruses: identification of isolates. In Diagnostic procedures for Viral, Rickettsial and Chlamydial Infections, 5th edn. pp 508–514 Lennette E. H., Schmidt N. J. Edited by Washington, D.C.: American Public Health Association;
    [Google Scholar]
21. O’Connell J. b., Reap E. A., Robinson J. A. 1986; The effects of cyclosporin on acute murine coxsackievirus B3 myocarditis. Circulation 73:353–359
    [Google Scholar]
22. Paque R. E., Gauntt C. J., Nealon T. J., Trousdale M. D. 1978; Assessment of cell-mediated hypersensitivity against coxsackie B3 virus-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. Journal of Immunology 120:1672–1678
    [Google Scholar]
23. Paque R. E., Straus D. c., Nealon T. J., Gauntt C. J. 1979; Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B-3. Journal of Immunology 123:358–364
    [Google Scholar]
24. Rager-Zisman B., Allison A. C. 1973; Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody. Journal of General Virology 19:339–351
    [Google Scholar]
25. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
26. Reyes M. P., Smith F. E., Lerner A. M. 1984; An enterovirus-induced murine model of an acute dilated-type cardiomyopathy. Intervirology 22:146–155
    [Google Scholar]
27. Rezkalla S., Khatib G., Khatib R. 1986; Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. Journal of Laboratory and Clinical Medicine 107:393–395
    [Google Scholar]
28. Robinson J. A., O’Connell J. B., Rogers L. M., Major E. O., Gunner R. M. 1981; Coxsackie B3 myocarditis in athymic mice. Proceedings of the Society for Experimental Biology and Medicine 166:80–91
    [Google Scholar]
29. Roesing T. G., Landau B. J., Crowell R. L. 1979; Limited persistence of viral antigen in coxsackievirus B3 induced heart muscle disease in mice. Proceedings of the Society for Experimental Biology and Medicine 160:382–386
    [Google Scholar]
30. Schnurr D. P., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice. Medical Microbiology and Immunology 173:1–7
    [Google Scholar]
31. Schnurr D. P., Cao Y., Schmidt N. J. 1984; Coxsackievirus B3 persistence and myocarditis in N :NIH(S) II nu/nu and +/nu mice. Journal of General Virology 65:1197–1201
    [Google Scholar]
32. Wilson F. M., Lerner A. M. 1978; A cardiomyopathy of Balb/c mice (superimposed infection by coxsackievirus B3). Proceedings of the Society for Experimental Biology and Medicine 157:442–448
    [Google Scholar]
33. Wolfgram L. J., Beisel K. W., Rose N. R. 1985; Heart-specific autoreactive antibodies following coxsackievirus B3 myocarditis. Journal of Experimental Medicine 161:1112–1121
    [Google Scholar]
34. Wong D. W., Woodruff J. J., Woodruff J. F. 1977a; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and virus specificity. Journal of Immunology 118:1159–1164
    [Google Scholar]
35. Wong D. W., Woodruff J. J., Woodruff J. F. 1977b; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral-infected myocardium. Journal of Immunology 118:1165–1169
    [Google Scholar]
36. Wong C. Y., Woodruff J. J., Woodruff J. F. 1977c; Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex. Journal of Immunology 119:591–597
    [Google Scholar]
37. Woodruff J. F. 1979; Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defence. Journal of Immunology 123:31–36
    [Google Scholar]
38. Woodruff J. F., Kilbourne E. D. 1970; The influence of quantitated post-weanling under-nutrition on coxsackievirus B3 infection of adult mice. 1. Viral persistence and increased severity of lesions. Journal of Infectious Diseases 121:137–163
    [Google Scholar]
39. Woodruff J. F., Woodruff J. J. 1974; Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. Journal of Immunology 113:1726–1734
    [Google Scholar]